Mapping the placental galectin-3 interactome identifies CD9 and ITGB1 as functional glycoprotein counter-receptors during syncytialization.

ABSTRACT: The fetomaternal interface is replete with glycan-binding proteins (GBPs) that can interact with cell surface glycoprotein counter-receptors to regulate placental function. Here, we interrogate the role of galectin-3, a GBP that controls placental trophoblast syncytialization, an important differentiation process where progenitor cytotrophoblast cells fuse to produce the multinucleated syncytiotrophoblast. The molecular mechanism of galectin-3-mediated fusion has not yet been elucidated in part due to the difficulty of studying glycan-GBP binding events in live cells. To overcome these challenges, we employ a proximity labeling strategy to identify the galectin-3 interactome. From this interactome dataset, we selected and validated CD9 and integrin beta 1 as functional counter-receptors of galectin-3 and showed that CD9 is glycosylated with an N-linked glycan at a rare non-canonical sequon. Furthermore, we present evidence that galectin-3 acts to physically alter the fluidity of the cellular membrane and it does not activate canonical syncytialization signaling pathways. Overall, we report that galectin-mediated binding events and their corresponding functions in cell biology can be precisely regulated by select glycoproteins at specific glycosites.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Mononuclear Cytotrophoblast Cell

SUBMITTER: Abigail Reeves  

LAB HEAD: Mia L Huang

PROVIDER: PXD069219 | Pride | 2025-11-24

REPOSITORIES: Pride